Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions

scientific article

Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJPB.2010.08.002
P698PubMed publication ID20719247
P5875ResearchGate publication ID45707238

P2093author name stringA Paillard Giteau
F Agnely
G Mekhloufi
J L Grossiord
S Huille
V Burckbuchler
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectrheologyQ271707
P304page(s)351-356
P577publication date2010-08-16
P1433published inEuropean Journal of Pharmaceutics and BiopharmaceuticsQ5412740
P1476titleRheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions
P478volume76

Reverse relations

cites work (P2860)
Q91847107An Empirical Quantitative Model Describing Simultaneously Temperature and Concentration Effects on Protein Solution Viscosity
Q47874488Assessing the Impact of Charge Variants on Stability and Viscosity of a High Concentration Antibody Formulation
Q54232655Assessment of Forces in Intradermal Injection Devices: Hydrodynamic Versus Human Factors.
Q90953690Assessment of the Injection Performance of a Tapered Needle for Use in Prefilled Biopharmaceutical Products
Q38090687Biopharmaceutical formulations for pre-filled delivery devices
Q42100850Carbon nanotubes play an important role in the spatial arrangement of calcium deposits in hydrogels for bone regeneration
Q61800021Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies
Q51101746Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody
Q92958909DEHP Nanodroplets Leached From Polyvinyl Chloride IV Bags Promote Aggregation of IVIG and Activate Complement in Human Serum
Q41596017Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection
Q38906930High concentration biotherapeutic formulation and ultrafiltration: Part 1 pressure limits
Q30462680High-throughput analysis of concentration-dependent antibody self-association.
Q90291008How Well Do Low- and High-Concentration Protein Interactions Predict Solution Viscosities of Monoclonal Antibodies?
Q90219306Impact of electroviscous effect on viscosity in developing highly concentrated protein formulations: Lessons from non-protein charged colloids
Q89976118In-Situ Forming pH and Thermosensitive Injectable Hydrogels to Stimulate Angiogenesis: Potential Candidates for Fast Bone Regeneration Applications
Q58798477Intra-Articular Formulation of GE11-PLGA Conjugate-Based NPs for Dexamethasone Selective Targeting-In Vitro Evaluation
Q42229593Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation
Q53354258Measuring tissue back-pressure--in vivo injection forces during subcutaneous injection.
Q42083252Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering
Q36067310Parallel temperature-dependent microrheological measurements in a microfluidic chip
Q37078347Small-angle neutron scattering characterization of monoclonal antibody conformations and interactions at high concentrations
Q39332318Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies
Q91296706Suck-Back Impact on Fluid Behavior at Filling Needle Tip
Q47367882Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions
Q47297020Viscosity Control of Protein Solution by Small Solutes: A Review

Search more.